EPO Patents = 3

Forward Citations = 11

Loading Chart...

9 inventors (with patents filed for the assignee):

Paul Hebeisen (4 out of 49 patents)

Florent Beaufils (4 out of 12 patents)

Jean-Baptiste Langlois (3 out of 6 patents)

4. Vladimir Cmiljanovic (2 out of 4 patents)

5. Thomas Bohnacker (2 out of 3 patents)

6. Matthias Wymann (2 out of 5 patents)

7. Denise Rageot (1 out of 4 patents)

8. Alexander Sele (1 out of 3 patents)

9. Eileen Jackson (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10766874 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2020-09-08),

2. 10640516 - Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines (2020-05-05),

3. 10100031 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2018-10-16),

4. 9556203 - Conformationally restricted P13K and mTOR inhibitors (2017-01-31),

Piqur Therapeutics Ag is a Swiss biotechnology company focused on the development of innovative cancer treatments. They specialize in targeted therapies for various types of cancer, with a particular emphasis on precision medicine and personalized treatment approaches. Their mission is to improve the lives of patients by advancing the field of oncology through cutting-edge research and advanced technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#72 in Basel

#1,949 in Switzerland

Basel, Switzerland

Piqur Therapeutics Ag